The somatostatin analog octreotide inhibits GH-stimulated, but not IGF-I-stimulated, bone growth in hypophysectomized rats.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Endocrinology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1210/en.143.8.2944PMID 12130560
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Molecular Cloning: A Laboratory Manual

  2001cited by this paper
• Effect of growth hormone and insulin-like growth factor I (IGF-I) on the expression of IGF-I messenger ribonucleic acid and peptide in rat tibial growth plate and articular chondrocytes in vivo.

  2000cited by this paper
• Effect of Growth Hormone and Insulin-Like Growth Factor I (IGF-I) on the Expression of IGF-I Messenger Ribonucleic Acid and Peptide in Rat Tibial Growth Plate and Articular Chondrocytes in Vivo.

  2000influential reference
• Changes in the circulating IGF system during short-term fasting and refeeding in rats.

  1999cited by this paper
• Leptin is suppressed during infusion of recombinant human insulin-like growth factor I (rhIGF I) in normal rats

  1999cited by this paper
• Liver-derived insulin-like growth factor I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice.

  1999cited by this paper
• Normal growth and development in the absence of hepatic insulin-like growth factor I.

  1999cited by this paper
• Regulation of growth hormone receptor gene expression.

  1998cited by this paper
• The molecular basis of growth hormone action.

  1998cited by this paper
• The effects of octreotide on GH receptor and IGF-I expression in the GH-deficient rat.

  1996cited by this paper
• Intravenously injected insulin-like growth factor (IGF) I/IGF binding protein-3 complex exerts insulin-like effects in hypophysectomized, but not in normal rats.

  1995cited by this paper
• The somatostatin receptor family.

  1995cited by this paper
• Expression and regulation of insulin-like growth factor-I (IGF-I) and IGF-binding protein messenger ribonucleic acid levels in tissues of hypophysectomized rats infused with IGF-I and growth hormone.

  1994cited by this paper
• Differential effects of insulin-like growth factor I and growth hormone on developmental stages of rat growth plate chondrocytes in vivo.

  1994influential reference
• Immunohistochemical localization of insulin-like growth factor 1 and 2 in the endocrine pancreas of rat, dog, and man, and their coexistence with classical islet hormones

  1993cited by this paper
• MOLECULAR BASIS OF GROWTH HORMONE ACTION

  1993cited by this paper
• Octreotide inhibits insulin-like growth factor-I hepatic gene expression in the hypophysectomized rat: evidence for a direct and indirect mechanism of action.

  1992influential reference
• Quantitative comparison of insulin-like growth factor mRNA levels in human and rat tissues analysed by a solution hybridization assay.

  1991cited by this paper
• Inhibitory effect of octreotide on growth hormone-induced IGF-I generation and organ growth in hypophysectomized rats.

  1991influential reference
• Somatostatin analogue, octreotide, reduces increased glomerular filtration rate and kidney size in insulin-dependent diabetes.

  1991cited by this paper
• Regulation by GH of insulin-like growth factor-I mRNA expression in rat epiphyseal growth plate as studied with in-situ hybridization.

  1990cited by this paper
• Somatostatin receptors are restricted to a subpopulation of osteoblast-like cells during endochondral bone formation.

  1990cited by this paper
• Dose-response study and long term effect of the somatostatin analog octreotide in patients with therapy-resistant acromegaly.

  1989cited by this paper
• Long term effects of continuous subcutaneous infusion of the somatostatin analog octreotide in the treatment of acromegaly.

  1989influential reference
• Physiological mechanisms adopted by chondrocytes in regulating longitudinal bone growth in rats.

  1989cited by this paper
• Regulation of insulin-like growth factor messenger ribonucleic acid in rat growth plate by growth hormone.

  1988cited by this paper
• Quantitation of chondrocyte performance in growth-plate cartilage during longitudinal bone growth.

  1987cited by this paper
• Mosaic evolution of the insulin-like growth factors. Organization, sequence, and expression of the rat insulin-like growth factor I gene.

  1987cited by this paper
• Regulation by growth hormone of number of chondrocytes containing IGF-I in rat growth plate.

  1986cited by this paper
• Evidence suggesting that the direct growth-promoting effect of growth hormone on cartilage in vivo is mediated by local production of somatomedin.

  1986cited by this paper
• Tissue concentrations of somatomedin C: further evidence for multiple sites of synthesis and paracrine or autocrine mechanisms of action.

  1984cited by this paper
• Growth hormone stimulates longitudinal bone growth directly.

  1982cited by this paper
• Radioimmunological determination of insulinlike growth factors I and II in normal subjects and in patients with growth disorders and extrapancreatic tumor hypoglycemia.

  1981cited by this paper
• Current Concepts of Somatomedin and Other Biologically Related Growth Factors

  1976cited by this paper
• Bioassay of hypophyseal growth hormone; the tibia test.

  1949cited by this paper

• Proton-pump inhibitor-induced bone loss is preventable by concomitant use of a long-acting somatostatin analogue

  2024cites this paper
• Rheumatic manifestations of acromegaly

  2020cites this paper
• Part A Long-term effects of acromegaly on joints and bone

  2015cites this paper
• Acromegalic arthropathy in various stages of the disease: a Magnetic Resonance Imaging (MRI) study

  2015cites this paper
• Comparative inhibition of the GH/IGF-I axis obtained with either the targeted secretion inhibitor SXN101959 or the somatostatin analog octreotide in growing male rats.

  2013cites this paper
• Two phenotypes of arthropathy in long-term controlled acromegaly? A comparison between patients with and without joint space narrowing (JSN).

  2013cites this paper
• Progression of acromegalic arthropathy despite long-term biochemical control: a prospective, radiological study.

  2012cites this paper
• Evaluation of four methods used to measure plasma insulin-like growth factor 1 concentrations in healthy cats and cats with diabetes mellitus or other diseases.

  2012cites this paper
• Serum IGF-I is not a reliable pharmacodynamic marker of exogenous growth hormone activity in mice.

  2011cites this paper
• Tumor-induced hypophosphatemic rickets in an adolescent boy--clinical presentation, diagnosis, and histological findings in growth plate and muscle tissue.

  2010cites this paper
• Pituitary-independent effect of octreotide on IGF1 generation.

  2009cites this paper
• Insulin‐Like Growth Factor‐I mRNA and Peptide in the Human Anterior Pituitary

  2007cites this paper
• Insulin‐like growth factor I (IGF‐I) and its receptor (IGF‐1R) in the rat anterior pituitary

  2007cites this paper
• Ethinylestradiol differentially interferes with IGF-I in liver and extrahepatic sites during development of male and female bony fish.

  2007cites this paper
• Measurements of growth hormone and insulin-like growth factor 1 in cats with diabetes mellitus

  2006cites this paper
• The effect of hypophysectomy on pancreatic islet hormone and insulin-like growth factor I content and mRNA expression in rat

  2005cites this paper
• Effects of insulin--like growth factor-I treatment on the endocrine pancreas of hypophysectomized rats: comparison with growth hormone replacement.

  2004cites this paper
• CLINICAL STUDY Progression of acromegalic arthropathy despite long-term biochemical control: a prospective, radiological study

  year unknowncites this paper